| Changes of blood-brain barrier and brain parenchymal protein expression levels of mice under different insulin-resistance conditions induced by high-fat diet S Ogata, S Ito, T Masuda, S Ohtsuki Pharmaceutical Research 36, 1-12, 2019 | 36 | 2019 |
| Characterization of P-glycoprotein humanized mice generated by chromosome engineering technology: its utility for prediction of drug distribution to the brain in humans Y Yamasaki, K Kobayashi, F Okuya, N Kajitani, K Kazuki, S Abe, ... Drug metabolism and disposition 46 (11), 1756-1766, 2018 | 29 | 2018 |
| Supersulphides provide airway protection in viral and chronic lung diseases T Matsunaga, H Sano, K Takita, M Morita, S Yamanaka, T Ichikawa, ... Nature communications 14 (1), 4476, 2023 | 26 | 2023 |
| Large-Scale Quantitative Comparison of Plasma Transmembrane Proteins between Two Human Blood–Brain Barrier Model Cell Lines, hCMEC/D3 and HBMEC/ciβ T Masuda, T Hoshiyama, T Uemura, M Hirayama-Kurogi, S Ogata, ... Molecular Pharmaceutics 16 (5), 2162-2171, 2019 | 24 | 2019 |
| Efficient isolation of brain capillary from a single frozen mouse brain for protein expression analysis S Ogata, S Ito, T Masuda, S Ohtsuki Journal of Cerebral Blood Flow & Metabolism 41 (5), 1026-1038, 2021 | 17 | 2021 |
| Identification of cell-surface proteins endocytosed by human brain microvascular endothelial cells in vitro S Ito, M Oishi, S Ogata, T Uemura, PO Couraud, T Masuda, S Ohtsuki Pharmaceutics 12 (6), 579, 2020 | 16 | 2020 |
| Persulfide biosynthesis conserved evolutionarily in all organisms S Ogata, T Matsunaga, M Jung, U Barayeu, M Morita, T Akaike Antioxidants & Redox Signaling 39 (13-15), 983-999, 2023 | 15 | 2023 |
| Supersulfide catalysis for nitric oxide and aldehyde metabolism S Kasamatsu, A Nishimura, MM Alam, M Morita, K Shimoda, T Matsunaga, ... Science advances 9 (33), eadg8631, 2023 | 15 | 2023 |
| Oral Coadministration of Zn-Insulin with d-Form Small Intestine-Permeable Cyclic Peptide Enhances Its Blood Glucose-Lowering Effect in Mice S Ito, Y Torii, S Chikamatsu, T Harada, S Yamaguchi, S Ogata, K Sonoda, ... Molecular Pharmaceutics 18 (4), 1593-1603, 2021 | 13 | 2021 |
| Involvement of an orphan transporter, SLC22A18, in cell growth and drug resistance of human breast cancer MCF7 cells S Ito, Y Fujino, S Ogata, M Hirayama-Kurogi, S Ohtsuki Journal of Pharmaceutical Sciences 107 (12), 3163-3170, 2018 | 13 | 2018 |
| Acetylation of the influenza A virus polymerase subunit PA in the N‐terminal domain positively regulates its endonuclease activity D Hatakeyama, M Shoji, S Ogata, T Masuda, M Nakano, T Komatsu, ... The FEBS Journal 289 (1), 231-245, 2022 | 11 | 2022 |
| Knockdown of orphan transporter SLC22A18 impairs lipid metabolism and increases invasiveness of HepG2 cells S Ito, G Honda, Y Fujino, S Ogata, M Hirayama-Kurogi, S Ohtsuki Pharmaceutical Research 36, 1-11, 2019 | 11 | 2019 |
| Diurnal changes in protein expression at the blood–brain barrier in mice S Ogata, S Ito, T Masuda, S Ohtsuki Biological and Pharmaceutical Bulletin 45 (6), 751-756, 2022 | 6 | 2022 |
| Proteomic evaluation of plasma membrane fraction prepared from a mouse liver and kidney using a bead homogenizer: Enrichment of drug-related transporter proteins R Yagi, T Masuda, S Ogata, A Mori, S Ito, S Ohtsuki Molecular Pharmaceutics 17 (11), 4101-4113, 2020 | 6 | 2020 |
| Proteomic alterations in the brain and blood–brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer’s disease S Ito, R Yagi, S Ogata, T Masuda, T Saito, T Saido, S Ohtsuki Fluids and Barriers of the CNS 20 (1), 66, 2023 | 5 | 2023 |
| Longevity control by supersulfide-mediated mitochondrial respiration and regulation of protein quality A Nishimura, S Yoon, T Matsunaga, T Ida, M Jung, S Ogata, M Morita, ... Redox biology 69, 103018, 2024 | 4 | 2024 |
| Development of a method for isolating brain capillaries from a single neonatal mouse brain and comparison of proteomic profiles between neonatal and adult brain capillaries Y Hamada, S Ogata, T Masuda, S Ito, S Ohtsuki Fluids and Barriers of the CNS 20 (1), 50, 2023 | 4 | 2023 |
| Influence of MDR1 gene polymorphism (2677G> T) on expression and function of P-glycoprotein at the blood-brain barrier: utilizing novel P-glycoprotein humanized mice with mutation Y Yamasaki, T Moriwaki, S Ogata, S Ito, S Ohtsuki, G Minegishi, S Abe, ... Pharmacogenetics and Genomics 32 (8), 288-292, 2022 | 4 | 2022 |
| Knockdown of podocalyxin post-transcriptionally induces the expression and activity of ABCB1/MDR1 in human brain microvascular endothelial cells H Nagano, S Ogata, S Ito, T Masuda, S Ohtsuki Journal of Pharmaceutical Sciences 111 (6), 1812-1819, 2022 | 4 | 2022 |
| Targeted proteomics for cancer biomarker verification and validation S Ogata, T Masuda, S Ito, S Ohtsuki Cancer Biomarkers 33 (4), 427-436, 2022 | 3 | 2022 |
